Skip to content
Screener

Kiniksa Pharmaceuticals International, plc KNSA Q3 2025 earnings

Reported October 28, 2025 · Before market open

Revenue$180.9MMiss by $16.2M
EPS$0.23Miss by $0.10
Revenue estimate$197.1M
EPS estimate$0.33

Next report

Oct 27, 2026 (in 3 months)
Revenue estimate$256.7M
EPS estimate$0.36

Financials

Q3 2025

Income statement

See full
Revenue$180.9M+61.2%
Gross profit$160.6M+74.4%
Operating income$24.0M+349%
Net income$18.4M+245%
EPS (diluted)$0.23+228%

Balance sheet

See full
Cash & equivalents$174.9M+79.6%
Total debt$9.7M-8.3%
Total equity$535.4M+22.5%
Total assets$712.3M+28.3%

Cash flow

See full
Operating cash flow$33.7M—
CapEx$671.0K—
Free cash flow$33.0M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$2.88B+62.2%
Enterprise value$2.71B+60.7%
P/E80.1×—
P/S4.8×+0.2×

Profitability

See full
Gross margin87.5%+1.2pp
Operating margin6.4%+4.2pp
Net margin6%+4.7pp
FCF margin17%+13.5pp

Returns & leverage

See full
Return on equity7.4%+6.0pp
Debt / equity0×0.0×
Current ratio3.8×+0.6×

Segments

By segment

See full
Pharmaceutical$180.9M+61.2%

By product

See full
Collaboration-—

FAQ

When did Kiniksa Pharmaceuticals International, plc report Q3 2025 earnings?
Kiniksa Pharmaceuticals International, plc (KNSA) reported Q3 2025 earnings on October 28, 2025 before market open.
What were Kiniksa Pharmaceuticals International, plc's Q3 2025 revenue and EPS?
Kiniksa Pharmaceuticals International, plc reported revenue of $180.9M and eps of $0.23 for Q3 2025.
Did Kiniksa Pharmaceuticals International, plc beat estimates in Q3 2025?
Revenue missed the consensus estimate of $197.1M by $16.2M. EPS missed the consensus estimate of $0.33 by $0.10.
How did Kiniksa Pharmaceuticals International, plc's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 61.2% from $112.2M a year earlier.
Where can I find Kiniksa Pharmaceuticals International, plc's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-102834) and the 10-Q periodic report (0001104659-25-103180) directly on SEC EDGAR. The filing index links above go to sec.gov.